65866-54-8 Usage
Uses
Used in Pharmaceutical Applications:
6-chloro-2-methyl[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one is used as a potential active pharmaceutical ingredient for the development of new drugs, leveraging its antimicrobial and antiviral properties. Its specific application in this industry is driven by the need for novel compounds to combat resistant strains of bacteria and viruses.
Used in Antimicrobial Agents:
In the field of antimicrobials, 6-chloro-2-methyl[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one is utilized as a compound with potential to inhibit the growth of various microorganisms. Its use is motivated by the search for new antimicrobial agents to address the increasing prevalence of antibiotic-resistant infections.
Used in Antiviral Agents:
Similarly, in antiviral applications, 6-chloro-2-methyl[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one is employed for its potential to inhibit viral replication and infection. The rationale for its use in this context is to develop new antiviral therapies, particularly in light of emerging viral diseases and the need for effective treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 65866-54-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,8,6 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 65866-54:
(7*6)+(6*5)+(5*8)+(4*6)+(3*6)+(2*5)+(1*4)=168
168 % 10 = 8
So 65866-54-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClN4O/c1-10-6(12)11-5(9-10)3-2-4(7)8-11/h2-3H,1H3
65866-54-8Relevant academic research and scientific papers
AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 44, (2010/10/20)
The present invention is directed to novel substituted aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
Condensed pyridazine compounds, their production and use
-
, (2008/06/13)
A condensed pyridazine derivative which exhibits anti-allergic activity, anti-histaminic activity and/or eosinophil chemotaxis-inhibiting activity, anti-inflammatory activity, anti-PAF (platelet-activating factor) activity, and the like, and is useful as
